Brennen Baylor focuses his practice on intellectual property matters in the life sciences industry. He prosecutes patent applications related to small molecules, pharmaceutical macromolecules, medical devices, agricultural chemistry, nutraceuticals, synthesis and use of nucleic acids and polypeptides, cell culturing systems and apparatuses, methods of culturing cells and methods of preparing tissue grafts. Brennen also has experience advising clients on inventions in the fields of chemical engineering systems, lithium batteries, manufacturing flooring composites, 3D printer filament compositions, and cellulose-based packaging materials.
Brennen develops go-to-market strategies for clients by providing detailed opinions on clients’ freedom to operate and patentability of inventions. He assesses potential infringement by competitors and validity of competitors’ intellectual property in anticipation of and preparation for litigation. Brennen also advises clients on comprehensive defense strategy in ongoing infringement litigation by providing invalidity and non-infringement analyses in coordination with co-counsel and expert witnesses.
In addition, Brennen assists clients by conducting due diligence on extensive pharmaceutical patent and trademark portfolios in connection with clients’ acquisition of competitors. He identifies risks associated with IP to be acquired and counsels clients on patent portfolio management strategy leading up to and following merger and restructuring.
